PACS Group (PACS) experienced a remarkable 44.44% surge over a 24-hour period on Wednesday, with the stock price soaring in both regular trading and after-hours sessions. This significant uptick comes on the heels of the company's release of its robust third-quarter financial results and an optimistic outlook for the full year 2025.

The healthcare operations company reported impressive third-quarter figures, with quarterly revenue reaching $1.34 billion, surpassing analyst expectations. This strong performance was complemented by PACS Group's forward-looking projections, which have clearly resonated with investors. The company anticipates full-year 2025 revenue to be between $5.3 billion and $5.4 billion, with adjusted EBITDA expected in the range of $480 million to $490 million.

Adding to investor confidence, PACS Group announced the completion of a restatement of previous financial statements, bringing the company current with SEC filing obligations. This move has bolstered trust in the company's financial transparency and governance. Furthermore, PACS Group's expansion strategy appears to be gaining traction, with its portfolio now including 320 healthcare operations across 17 states, ownership of 51 facilities, and purchase options on an additional 59 facilities. The company's commitment to growth through a combination of leasing, acquisitions, and evaluating opportunities in both high-performing and underperforming operations has clearly struck a chord with the market, contributing to the significant stock price surge.